CLDN6 and neoplasm: Of course, altered metabolic pathways upon CLDN6 overexpression such as purine, pyrimidine, and fatty acid biosynthesis metabolism may also contribute to the inhibitory effect of CLDN6 on tumor growth, which is our ongoing research.